Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary report

References

• Skinner M, Anderson J, Simms R, Falk R, Wang M, Libbey C, Jones LA, Cohen AS. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 1996;100:290–298.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45–59.
   PubMed Web of Science ®Google Scholar
• Gertz MA, Kyle RA, Greipp PR. Response rates and survival in primary systemic amyloidosis. Blood 1991;77:257–262.
   PubMed Web of Science ®Google Scholar
• Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998;91:141–157.
   PubMed Web of Science ®Google Scholar
• Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005;165:1425–1429.
   PubMed Web of Science ®Google Scholar
• Lehrke S, Steen H, Kristen AV, Merten C, Lossnitzer D, Dengler TJ, Katus HA, Giannitsis E. Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis. Amyloid 2009;16:187–195.
   PubMed Web of Science ®Google Scholar
• Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004;140:85–93.
   PubMed Web of Science ®Google Scholar
• Saba N, Sutton D, Ross H, Siu S, Crump R, Keating A, Stewart A. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant 1999;24:853–855.
   PubMed Web of Science ®Google Scholar
• Liao R, Jain M, Teller P, Connors LH, Ngoy S, Skinner M, Falk RH, Apstein CS. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation 2001;104:1594–1597.
   PubMed Web of Science ®Google Scholar
• Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M, Apstein CS, Liao R. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 2004;94:1008–1010.
   PubMed Web of Science ®Google Scholar
• Shi J, Guan J, Jiang B, Brenner DA, Del Monte F, Ward JE, Connors LH, et al. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38α MAPK pathway. Proc Natl Acad Sci USA 2010;107:4188–4193.
   PubMed Web of Science ®Google Scholar
• Sikkink LA, Ramirez-Alvarado M. Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture. Cell Death Dis 2010;1:e98.
   PubMed Web of Science ®Google Scholar
• Ward JE, Ren R, Toraldo G, Soohoo P, Guan J, O’Hara C, Jasuja R, et al. Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis. Blood 2011;118:6610–6617.
   PubMed Web of Science ®Google Scholar
• Shin JT, Fishman MC. From Zebrafish to human: modular medical models. Annu Rev Genomics Hum Genet 2002;3:311–340.
   PubMed Web of Science ®Google Scholar
• Shin JT, Pomerantsev EV, Mably JD, MacRae CA. High-resolution cardiovascular function confirms functional orthology of myocardial contractility pathways in zebrafish. Physiol Genomics 2010;42:300–309.
   PubMed Web of Science ®Google Scholar
• Peal DS, Mills RW, Lynch SN, Mosley JM, Lim E, Ellinor PT, January CT, et al. Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation 2011;123:23–30.
   PubMed Web of Science ®Google Scholar
• Milan DJ, Kim AM, Winterfield JR, Jones IL, Pfeufer A, Sanna S, Arking DE, et al. Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation 2009;120:553–559.
   PubMed Web of Science ®Google Scholar
• Milan DJ, Jones IL, Ellinor PT, MacRae CA. In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol 2006;291:H269–H273.
   PubMed Web of Science ®Google Scholar
• Heuser A, Plovie ER, Ellinor PT, Grossmann KS, Shin JT, Wichter T, Basson CT, et al. Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2006;79:1081–1088.
   PubMed Web of Science ®Google Scholar
• Lee JS, Yu Q, Shin JT, Sebzda E, Bertozzi C, Chen M, Mericko P, et al. Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev Cell 2006;11:845–857.
   PubMed Web of Science ®Google Scholar
• Schönberger J, Wang L, Shin JT, Kim SD, Depreux FF, Zhu H, Zon L, et al. Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat Genet 2005;37:418–422.
   PubMed Web of Science ®Google Scholar
• Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 4th ed. Eugene, OR: The University of Oregon Press; 2000.
   Google Scholar
• Horng JL, Lin LY, Hwang PP. Functional regulation of H+-ATPase-rich cells in zebrafish embryos acclimated to an acidic environment. Am J Physiol, Cell Physiol 2009;296:C682–C692.
   Google Scholar